GILEAD SCIENCES INC (GILD) Fundamental Analysis & Valuation
NASDAQ:GILD • US3755581036
Current stock price
130.4 USD
-3.24 (-2.42%)
At close:
130.4 USD
0 (0%)
After Hours:
This GILD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GILD Profitability Analysis
1.1 Basic Checks
- In the past year GILD was profitable.
- In the past year GILD had a positive cash flow from operations.
- GILD had positive earnings in each of the past 5 years.
- GILD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- GILD has a better Return On Assets (14.42%) than 94.96% of its industry peers.
- GILD's Return On Equity of 37.49% is amongst the best of the industry. GILD outperforms 97.87% of its industry peers.
- With an excellent Return On Invested Capital value of 19.49%, GILD belongs to the best of the industry, outperforming 97.29% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for GILD is significantly below the industry average of 27.75%.
- The last Return On Invested Capital (19.49%) for GILD is above the 3 year average (17.55%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROIC | 19.49% |
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
1.3 Margins
- GILD has a Profit Margin of 28.90%. This is amongst the best in the industry. GILD outperforms 94.38% of its industry peers.
- In the last couple of years the Profit Margin of GILD has grown nicely.
- GILD's Operating Margin of 39.98% is amongst the best of the industry. GILD outperforms 97.67% of its industry peers.
- In the last couple of years the Operating Margin of GILD has remained more or less at the same level.
- The Gross Margin of GILD (78.83%) is better than 84.11% of its industry peers.
- In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% |
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
2. GILD Health Analysis
2.1 Basic Checks
- GILD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, GILD has less shares outstanding
- GILD has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, GILD has an improved debt to assets ratio.
2.2 Solvency
- GILD has an Altman-Z score of 4.36. This indicates that GILD is financially healthy and has little risk of bankruptcy at the moment.
- GILD has a better Altman-Z score (4.36) than 72.29% of its industry peers.
- GILD has a debt to FCF ratio of 2.64. This is a good value and a sign of high solvency as GILD would need 2.64 years to pay back of all of its debts.
- The Debt to FCF ratio of GILD (2.64) is better than 93.02% of its industry peers.
- A Debt/Equity ratio of 0.97 indicates that GILD is somewhat dependend on debt financing.
- GILD's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. GILD is outperformed by 75.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Altman-Z | 4.36 |
ROIC/WACC2.1
WACC9.27%
2.3 Liquidity
- GILD has a Current Ratio of 1.55. This is a normal value and indicates that GILD is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.55, GILD is doing worse than 82.17% of the companies in the same industry.
- A Quick Ratio of 1.40 indicates that GILD should not have too much problems paying its short term obligations.
- GILD has a Quick ratio of 1.40. This is amonst the worse of the industry: GILD underperforms 82.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 |
3. GILD Growth Analysis
3.1 Past
- GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
- GILD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
- The Revenue has been growing slightly by 2.40% in the past year.
- GILD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.58% yearly.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
3.2 Future
- Based on estimates for the next years, GILD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.02% on average per year.
- Based on estimates for the next years, GILD will show a small growth in Revenue. The Revenue will grow by 5.47% on average per year.
EPS Next Y8.48%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
EPS Next 5Y10.02%
Revenue Next Year3.45%
Revenue Next 2Y4.74%
Revenue Next 3Y4.91%
Revenue Next 5Y5.47%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. GILD Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 16.00, which indicates a correct valuation of GILD.
- 94.96% of the companies in the same industry are more expensive than GILD, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.42. GILD is valued slightly cheaper when compared to this.
- With a Price/Forward Earnings ratio of 14.75, GILD is valued correctly.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GILD indicates a rather cheap valuation: GILD is cheaper than 96.32% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, GILD is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | 14.75 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GILD is valued cheaper than 95.16% of the companies in the same industry.
- 95.93% of the companies in the same industry are more expensive than GILD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.12 | ||
| EV/EBITDA | 12.39 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of GILD may justify a higher PE ratio.
PEG (NY)1.89
PEG (5Y)5.66
EPS Next 2Y9.83%
EPS Next 3Y9.44%
5. GILD Dividend Analysis
5.1 Amount
- GILD has a Yearly Dividend Yield of 2.45%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.71, GILD pays a better dividend. On top of this GILD pays more dividend than 98.64% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, GILD pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
5.2 History
- The dividend of GILD has a limited annual growth rate of 3.30%.
- GILD has been paying a dividend for at least 10 years, so it has a reliable track record.
- GILD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
- 47.04% of the earnings are spent on dividend by GILD. This is a bit on the high side, but may be sustainable.
- GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP47.04%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
GILD Fundamentals: All Metrics, Ratios and Statistics
130.4
-3.24 (-2.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10 2026-02-10/amc
Earnings (Next)04-30 2026-04-30
Inst Owners92.8%
Inst Owner Change-0.06%
Ins Owners0.1%
Ins Owner Change1.55%
Market Cap161.86B
Revenue(TTM)29.44B
Net Income(TTM)8.51B
Analysts81.54
Price Target161.35 (23.73%)
Short Float %1.74%
Short Ratio3.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.45% |
Yearly Dividend3.22
Dividend Growth(5Y)3.3%
DP47.04%
Div Incr Years10
Div Non Decr Years10
Ex-Date03-13 2026-03-13 (0.82)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.2%
Min EPS beat(2)0.73%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)3.61%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)7.27%
EPS beat(16)12
Avg EPS beat(16)9.04%
Revenue beat(2)2
Avg Revenue beat(2)1.64%
Min Revenue beat(2)0.98%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)2.29%
Revenue beat(8)6
Avg Revenue beat(8)1.67%
Revenue beat(12)8
Avg Revenue beat(12)0.99%
Revenue beat(16)12
Avg Revenue beat(16)2.6%
PT rev (1m)1.47%
PT rev (3m)17.65%
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)-8.23%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-0.31%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16 | ||
| Fwd PE | 14.75 | ||
| P/S | 5.5 | ||
| P/FCF | 17.12 | ||
| P/OCF | 16.16 | ||
| P/B | 7.13 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.39 |
EPS(TTM)8.15
EY6.25%
EPS(NY)8.84
Fwd EY6.78%
FCF(TTM)7.62
FCFY5.84%
OCF(TTM)8.07
OCFY6.19%
SpS23.72
BVpS18.29
TBVpS-2.09
PEG (NY)1.89
PEG (5Y)5.66
Graham Number57.9132 (-55.59%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROCE | 24.94% | ||
| ROIC | 19.49% | ||
| ROICexc | 25.18% | ||
| ROICexgc | 81.81% | ||
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% | ||
| FCFM | 32.11% |
ROA(3y)8.12%
ROA(5y)8.16%
ROE(3y)21.59%
ROE(5y)23.19%
ROIC(3y)17.55%
ROIC(5y)16.76%
ROICexc(3y)21.91%
ROICexc(5y)20.22%
ROICexgc(3y)88.7%
ROICexgc(5y)94.18%
ROCE(3y)22.46%
ROCE(5y)21.44%
ROICexgc growth 3Y-8.45%
ROICexgc growth 5Y-2.47%
ROICexc growth 3Y8.85%
ROICexc growth 5Y10%
OM growth 3Y-1.4%
OM growth 5Y-0.11%
PM growth 3Y19.75%
PM growth 5Y125.27%
GM growth 3Y-0.18%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 20.4% | ||
| Cap/Sales | 1.91% | ||
| Interest Coverage | 11.36 | ||
| Cash Conversion | 68.94% | ||
| Profit Quality | 111.11% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 4.36 |
F-Score8
WACC9.27%
ROIC/WACC2.1
Cap/Depr(3y)20.34%
Cap/Depr(5y)24.78%
Cap/Sales(3y)1.96%
Cap/Sales(5y)2.14%
Profit Quality(3y)796.33%
Profit Quality(5y)548.85%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y8.48%
EPS Next 2Y9.83%
EPS Next 3Y9.44%
EPS Next 5Y10.02%
Revenue 1Y (TTM)2.4%
Revenue growth 3Y2.57%
Revenue growth 5Y3.58%
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.74%
Revenue Next 3Y4.91%
Revenue Next 5Y5.47%
EBIT growth 1Y8.73%
EBIT growth 3Y1.14%
EBIT growth 5Y3.47%
EBIT Next Year26.16%
EBIT Next 3Y11.46%
EBIT Next 5Y10.72%
FCF growth 1Y-8.25%
FCF growth 3Y4.25%
FCF growth 5Y4.69%
OCF growth 1Y-7.48%
OCF growth 3Y3.36%
OCF growth 5Y4.17%
GILEAD SCIENCES INC / GILD Fundamental Analysis FAQ
What is the ChartMill fundamental rating of GILEAD SCIENCES INC (GILD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to GILD.
What is the valuation status for GILD stock?
ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GILD). This can be considered as Fairly Valued.
What is the profitability of GILD stock?
GILEAD SCIENCES INC (GILD) has a profitability rating of 8 / 10.
What is the expected EPS growth for GILEAD SCIENCES INC (GILD) stock?
The Earnings per Share (EPS) of GILEAD SCIENCES INC (GILD) is expected to grow by 8.48% in the next year.
Is the dividend of GILEAD SCIENCES INC sustainable?
The dividend rating of GILEAD SCIENCES INC (GILD) is 7 / 10 and the dividend payout ratio is 47.04%.